An Early Step on Collaboration on Cancer Drugs

Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://query.nytimes.com/gst/abstract.html?res=FB0D12FB3B5B0C708DDDAC0894DB404482

Business/Financial Desk | May 13, 2003, Tuesday
An Early Step on Collaboration on Cancer Drugs

By ANDREW POLLACK (NYT) 871 words
Late Edition - Final , Section C , Page 1 , Column 3

ABSTRACT - Pharmaceutical companies are beginning to contemplate new collaborative efforts to lower cost and speed development of drugs for cancer; task force will present preliminary proposal on collaborative drug development to pharmaceutical industry chief executives at meeting in Washington on June 6; Dr Gabriel Leung, co-chairman of task force, who was head of oncology at Pharmacia until its recent acquisition by Pfizer, says drug industry consortium will conduct or finance research aimed at understanding underlying mechanisms of cancer; Robert Ingram, vice chairman for pharmaceuticals at GlaxoSmithKline, says pharmaceutical companies need to cooperate on drug development because drugs in future will be tailored for patients based on their genetic makeup; photos (M) Pharmaceutical companies are beginning to contemplate new collaborative efforts to lower the cost and speed the development of drugs for cancer, according to executives involved in the effort.

The ideas for such initiatives are still in their infancy and may never come to fruition, these executives said. Still, a task force will present a preliminary proposal on collaborative drug development to pharmaceutical industry chief executives at a meeting in Washington on June 6. The task force is expected to propose the creation of a research organization modeled partly on Sematech, a research consortium set up by the semiconductor industry in the 1980's to improve basic techniques for making computer chips.

PURCHASING FROM NYTIMES.COM IS QUICK AND SECURE.
To read the complete article, simply click on one of the BUY NOW buttons below.

You can buy this single article or, for even greater value, you can purchase this article as part of a multi-pack. You'll then have the opportunity to buy additional articles now or in the future at significant savings!
 
Purchase Single Article -- $2.95  
Purchase as part of Article 4-Pack -- $7.95
($1.99/article - a 33% savings!)
Pack expires after 1 month
 		  
Purchase as part of Article 10-Pack -- $15.95
($1.60/ article - a 46% savings!)
Pack expires after 3 months
 		  
Purchase as part of Article 25-Pack -- $25.95
($1.05/ article - a 65% savings!)
Pack expires after 6 months
 		  

How multi-packs work: A multi-pack is an archive package that saves you money by allowing you to pre-purchase a set number of articles in bulk at a reduced price. You can then debit from your multi-pack and quickly access articles from the archive at your convenience over the lifetime of the multi-pack.

Once you purchase an article, you may view it as often as you like over the next 90 days. Archive articles do not include photos, charts or graphics

Click here to purchase article if you already own an archive article pack.

 

Vaccination News Home Page

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.